Anlon Healthcare

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
15.86
-0.12 (-0.75%)
BSENSE

Jun 18

BSE+NSE Vol: 36.85 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

36.85 lacs (-28.67%) Volume

Shareholding (Mar 2026)

FII

0.32%

Held by 5 FIIs

DII

4.60%

Held by 1 DIIs

Promoter

52.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 843 Cr ()

stock-summary
P/E

31.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

3.96

Revenue and Profits:
Net Sales:
51 Cr
(Quarterly Results - Mar 2026)
Net Profit:
10 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
38.82%
0%
38.82%
6 Months
18.23%
0%
18.23%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Invitation For TV Interview On NDTV Profit.

11-Jun-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Intimation Regarding Media Interaction Of Chairman & Managing Director

09-Jun-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

09-Jun-2026 | Source : BSE

We have attached herewith earning call transcript as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

stock-summary
BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.24
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
31.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.92%
ROCE (avg)
9.07%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
34
Price to Book Value
3.96
EV to EBIT
19.29
EV to EBITDA
18.72
EV to Capital Employed
3.77
EV to Sales
4.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.57%
ROE (Latest)
12.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (0.32%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

24.38%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 55.76% vs -31.84% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 90.10% vs -44.74% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.42",
          "val2": "35.58",
          "chgp": "55.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.91",
          "val2": "12.27",
          "chgp": "13.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.18",
          "val2": "1.51",
          "chgp": "-21.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.79",
          "val2": "5.15",
          "chgp": "90.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.10%",
          "val2": "34.49%",
          "chgp": "-9.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Anlon Healthcare"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Anlon Healthcare"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.50",
          "val2": "120.29",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.14",
          "val2": "32.21",
          "chgp": "43.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.35",
          "val2": "3.72",
          "chgp": "16.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.81",
          "val2": "20.52",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.14%",
          "val2": "26.78%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary
Mar'26
Dec'25
Change(%)
Net Sales
55.42
35.58
55.76%
Operating Profit (PBDIT) excl Other Income
13.91
12.27
13.37%
Interest
1.18
1.51
-21.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.79
5.15
90.10%
Operating Profit Margin (Excl OI)
25.10%
34.49%
-9.39%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 55.76% vs -31.84% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 90.10% vs -44.74% in Dec 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
176.50
120.29
46.73%
Operating Profit (PBDIT) excl Other Income
46.14
32.21
43.25%
Interest
4.35
3.72
16.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
27.81
20.52
35.53%
Operating Profit Margin (Excl OI)
26.14%
26.78%
-0.64%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details